David Tapolczay

David Tapolczay

Algemeen Directeur bij CONDUIT PHARMACEUTICALS INC.

Vermogen: 6 M $ op 30-04-2024

64 jaar
Commercial Services
Health Technology
Consumer Services

Profiel

David Joszef Tapolczay founded Sigma Entity One Ltd.
in 2003, where he worked as Chairman & Chief Executive Officer, Nuformix Technologies Ltd.
in 2007, where he worked as Non-Executive Chairman from 2007 to 2020, and Nuformix Plc in 2008, where he worked as Non-Executive Chairman from 2008 to 2020.
Dr. Tapolczay also currently works at Conduit Pharmaceuticals, Inc., as Chief Executive Officer & Director from 2023, Medeor Old Ltd., as Director, Medeor LLP, as Director, and Medeor Pharma Ltd., as Director.
Dr. Tapolczay also formerly worked at The Medical Research Council, as Chief Executive Officer, Lifearc, as Chief Executive Officer from 2008 to 2018, Stylacats Ltd., as Chief Executive Officer, Intelligent OMICS Ltd., as Non-Executive Chairman, Bicycle Therapeutics Plc, as Director, Nanoform Cardiovascular Therapeutics Ltd., as Director, Zeneca Agrochemicals, as Manager in 2013, Cambridge Discovery Chemistry, as Vice President-Research & Development, Glaxo Smithkline Plc, as Senior Manager-Chemical Development, GSK Pharmaceutical Trading SA, as VP-Technology Development from 2005 to 2007, Millenium Group Ltd., as Senior Vice President-Pharmaceutical Sciences, Sigma-Aldrich Co. Ltd., as Chief Scientific Officer, and GSK Group Ltd., as Vice President-Technology Development.
Dr. Tapolczay received his undergraduate degree and doctorate degree from Southampton Business School.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
01-05-2024 2 003 324 ( 2.71% ) 6 M $ 30-04-2024

Actieve functies van David Tapolczay

BedrijvenFunctieBegin
CONDUIT PHARMACEUTICALS INC. Algemeen Directeur 22-09-2023
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Directeur/Bestuurslid -
Alle actieve functies van David Tapolczay

Eerdere bekende functies van David Tapolczay

BedrijvenFunctieEinde
Oprichter 05-02-2020
NUFORMIX PLC Oprichter 05-02-2020
Algemeen Directeur 01-12-2018
Hoofd Techniek/Wetenschap/O&O 01-04-2007
Glaxo Smithkline Plc /Clinical Pharmacology Unit/ Corporate Officer/Principal -
Ervaring van David Tapolczay in detail bekijken

Opleiding van David Tapolczay

Southampton Business School Doctorate Degree

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Ervaring van David Tapolczay in detail bekijken

Connecties

25

Eerstegraads connecties

21

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Persoonlijk netwerk weergeven

Verwante bedrijven

Beursgenoteerde bedrijven3
BICYCLE THERAPEUTICS PLC

Health Technology

NUFORMIX PLC

Health Technology

CONDUIT PHARMACEUTICALS INC.

Health Technology

Bedrijven in privébezit17
Zeneca Agrochemicals

Glaxo Smithkline Plc /Clinical Pharmacology Unit/

Commercial Services

Commercial Services

Commercial Services

Health Technology

GSK Group Ltd.

Commercial Services

Commercial Services

Health Technology

Stylacats Ltd.

Commercial Services

Health Technology

Commercial Services

Commercial Services

Commercial Services

Nanoform Cardiovascular Therapeutics Ltd.

Health Technology

Zie bedrijfsconnecties
  1. Beurs
  2. Insiders
  3. David Tapolczay
-40 % Aanbod van beperkte duur: onze abonnementen leiden je naar de beste beleggingen van morgen.
PROFITEER NU